Unraveling the Mechanisms Behind FMT Efficacy

Already successful in treating C difficile, fecal microbiota transplant could be applied to noncommunicable diseases, but better understanding of donor-recipient pairing is critical.

Related Keywords

Shahid Beheshti ,Yazd ,Iran ,Rhode Island ,United States ,Tehran ,Rome ,Lazio ,Italy ,Serena Porcari ,Fondazione Policlinico Universitario Gemelli ,Colleen Kelly ,Gianluca Ianiro ,Abbas Yadegar ,National Patient Registry ,Brown University In Providence ,Sebela Pharmaceuticals ,Shahid Beheshti University Of Medical Sciences ,National Institute Of Allergy ,Rebiotix Ferring Pharmaceuticals ,Drug Administration ,Cell Host ,Shahid Beheshti University ,Medical Sciences ,Medscape Medical ,Cattolica Del Sacro Cuore ,Closer Look ,Donor Recipient Pairings ,Possible Role ,Medscape Medical News ,Sustained Response ,Brown University ,Finch Therapeutics ,Patient Registry ,National Institute ,Infectious Diseases ,National Institutes ,C Diff Infection ,Clostridium Difficile Infection ,Lostridium Difficile Associated Disease ,C Diff Associated Disease ,Biologic Therapy ,Fecal Transplantation ,Stool Transplant ,Ecal Bacteriotherapy ,Fecal Microbiota Transplantation ,Mt ,Microbiome ,Bacteria ,Diet ,Transplantation ,Transplant ,Genomics ,Genomic Medicine ,Edicine Genomic ,Genetics ,Ulcerative Colitis ,